Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Cognition Disorders × Lovastatin × CNS × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neurofibromatosis 1 5 Noonan Syndrome 1 Learning Disabilities 1 Inhibition, Psychological 1 Dyslexia 1 Cognition Disorders 1 Autism Spectrum Disorder 1

Interventions

Spermine Synthase 1 Radiosurgery 1 Modafinil 1 Mental Status and Dementia Tests 1 Lovastatin 1 Lomustine 1 Lamotrigine 1 DNA Methylation 1 Cognitive Training 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03504501 2023-11-30

SynCoRAS

Technical University of Munich

Phase 2 Terminated

Cognition Disorders, Neurofibromatosis 1, Noonan Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡